About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials | 8,034 Studies Recruiting

Clinical TrialsLung Cancer

Lung Cancer Clinical Trials

Browse 8,034 clinical trials for lung cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2281-2300 of 8,034 trials

CompletedCelecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung CancerRATIONALE: Studying samples of tissue, blood, and urine from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify…NCT00653250 CompletedErlotinib in Treating Patients With Advanced Non-Small Cell Lung CancerRATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00416650·Chicago, Illinois and 3 others Active not recruitingPembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC)The main purpose of this study is to see whether the combination of two drugs called pembrolizumab and vorinostat can help people with advanced lung cancer.NCT02638090·Tampa, Florida CompletedMicro RNA Genetic Signature in NSCLC Egyptian PatientsThis study will be carried out on 40 subjects at Chest department Tanta university hospital The subjects will be classified into three groups: * Group I: will include ten non…NCT02445924·Tanta, Gharbia Governorate

Related Searches

nsclctrials sclctrials lung carcinomatrials

Data from ClinicalTrials.govTerms

CompletedPaclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung CancerRATIONALE: Drugs used in chemotherapy such as paclitaxel and carboplatin use different ways to stop tumor cells from dividing so they stop growing or die.NCT00062179·Los Angeles, California and 1 other

TerminatedPhase I Dose Escalation and Expansion of Oral BAY 1143269 in Combination With Intravenous DocetaxelDetermine the safety, tolerability, maximum tolerated dose (MTD), pharmacokinetics (PK), and/or recommended Phase II dose (RP2D) of oral BAY 1143269 given alone or in combination…NCT02439346·Dallas, Texas and 3 others

CompletedStudy of Alkotinib in Patients With Advanced Non Small Cell Lung CancerTo explore the DLT of ZG0418 for Patients with Advanced ALK+ or ROS1+ NSCLC And Previously Treated with Chemotherapy or Crizotinib, and to determine the MTD or the R2PD.NCT03607188·Shanghai, Shanghai Municipality

CompletedA Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Participants With Lung Cancer Who Have Not Received Chemotherapy BeforeThe purpose of this study is to determine the number of participants whose cancer shrinks or disappears after treatment on the study.NCT00870870·Anniston, Alabama and 11 others

UnknownCamrelizumab With Apatinib as Neoadjuvant Therapy for Participants With Resectable Non-Small Cell Lung CancerThis trial will evaluate the safety and efficacy of Camrelizumab (SHR-1210) in combination with apatinib neoadjuvant therapy before surgery \[neoadjuvant phase\], followed by…NCT04506242

CompletedA Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung CancerSubjects who qualify will receive single agent lenalidomide once daily on days 1-21 of 28 day cycles. Subjects will continue until disease progression is documented.NCT00179686·Birmingham, Alabama and 5 others

CompletedTrial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic CancersThe main purpose of this study is to determine how best to combine hypofractionated radiotherapy, MEDI4736, and tremelimumab and to determine how safe and tolerable…NCT02639026·Philadelphia, Pennsylvania

CompletedThyroid Dysfunction and Nivolumab Reponse in NSCLCThis is an observational, retrospective and monocentric study, conducted at the university Hospital of Brest The primary objective is to assess the association between the…NCT04470440·Brest

UnknownStudy of 3D Radiotherapy With or Without Erlotinib (Tarceva®) in Patients With Localized Non-Small Cell Lung CancerA phase II, multicenter, randomized trial of 3D Radiotherapy versus 3D Radiotherapy and erlotinib (Tarceva®) in patients with localized-unresectable (IA-IIIB) non-small cell lung…NCT00466089·Barcelona, Barcelona and 4 others

RecruitingMicrowave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy FailureThe purpose of this clinical trial is to evaluate progression-free survival (PFS) of microwave ablation in combination with tislelizumab and docetaxel in patients with advanced…NCT07528274·Tianjin, Tianjin Municipality

UnknownPhase 1/2 Study of HS-10376 in Patients With Non-Small Cell Lung CancerHS-10376 is an oral, highly selective, small molecular inhibitor of EGFR/HER2 Exon 20 insertion mutation.NCT05435274·Tianjin, Tianjin Municipality

TerminatedPhase 1/2 Study of BBT-176 in Advanced NSCLC With Progression After EGFR TKI TreatmentThis clinical trial is the first-in-human study of BBT-176.NCT04820023·Seongnam-si, Gyeonggi-do and 3 others

RecruitingStudy of CXCR5 Modified EGFR Targeted CAR-T Cells for Advanced NSCLCThis study is a single arm, open-label, intravenous infusion of Anti- Epidermal growth factor receptor (EGFR) Chimeric Antigen Receptor (CAR) T cells modified by C-X-C Chemokine…NCT05060796·Guangzhou

CompletedAn Observational Study to Evaluate the Clinical Utility of the Oncomine Precision Assay Within the Exactis NetworkA Multi-centre Observational Study to Evaluate the Clinical Utility of Returning Genomic Aberration results Using the Oncomine Precision Assay in Advanced or Metastatic Non-Small…NCT04564079·Moncton, New Brunswick and 5 others

WithdrawnCT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mLThis study is designed to test whether CT-2103/carboplatin provides improved overall survival compared to paclitaxel/carboplatin in women with NSCLC who have estradiol levels \>30…NCT00576225·Scottsdale, Arizona and 43 others

CompletedCombination Chemotherapy With or Without Radiation Therapy in Treating Patients With Stage IIIA Non-small Cell Lung CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00003317·Scottsdale, Arizona and 15 others

PreviousPage 115 of 402Next